Biodesix Clears Key Benchmark, Hitting 80-Plus RS Rating
Biodesix’s stock performance recently moved into a higher bracket, with its IBD Relative Strength Rating rising from 70 to 84. This upgrade means the company has topped a critical 80-plus threshold, signaling improved market traction.
1 week ago
1 min read